HELICOBACTER PYLORI CAGA/VACAS1-M1 STRAIN IS ASSOCIATED WITH HIGH RISK OF FIBROSIS IN METABOLIC-DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引:0
|
作者
Barreyro, Fernando [1 ]
Maiorana, Facundo [1 ]
Neschuk, Magali [1 ]
Caronia, Maria Viriginia [1 ]
Elizondo, Karina [2 ]
Schneider, Adolfo [2 ]
Veron, Georgina [2 ]
Zapata, Pedro Dario [1 ]
机构
[1] Natl Univ Misiones, Misiones, Argentina
[2] Barcelo Univ Inst Hlth Sci, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1200
引用
收藏
页码:S914 / S915
页数:2
相关论文
共 50 条
  • [1] Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fi brosis in metabolic-dysfunction-associated steatotic liver disease
    Maiorana, Facundo
    Neschuk, Magali
    Caronia, Maria Virginia
    Elizondo, Karina
    Schneider, Adolfo
    Veron, Georgina
    Zapata, Pedro
    Barreyro, Fernando Javier
    ANNALS OF HEPATOLOGY, 2024, 29 (06)
  • [2] Helicobacter pylori Infection and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Pyrrou, Nikoletta
    Kountouras, Jannis
    DIGESTIVE DISEASES, 2025, 43 (02) : 253 - 256
  • [3] Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 287 - 299
  • [4] Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
    de Abreu, Joana D'Arc Matos Franca
    Azulay, Rossana Sousa
    Rodrigues, Vandilson
    de Abreu, Sterffeson Lamare Lucena
    Tavares, Maria da Gloria
    Pinheiro, Flavia Coelho Mohana
    de Oliveira Neto, Clariano Pires
    Andrade, Caio
    Facundo, Alexandre
    Sa, Adriana Guimaraes
    Azevedo, Patricia Ribeiro
    de Almeida, Ana Gregoria Pereira
    Costa, Debora Camelo de Abreu
    Castro, Rogerio Soares
    Magalhaes, Marcelo
    Nascimento, Gilvan Cortes
    Faria, Manuel dos Santos
    Ferreira, Adalgisa de Souza Paiva
    BIOMEDICINES, 2024, 12 (11)
  • [5] Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kim, Jun Young
    Kwan, Byung Soo
    Cho, Jung Hwan
    Kim, Hye In
    Ko, Nak Gyeong
    Jin, Mihyeon
    Lee, Ok Jae
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [6] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
  • [7] Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
    Vega, Luis
    Simian, Daniela
    Gajardo, Abraham I.
    Salinas, Marcelo
    Urra, Andrea
    Cattaneo, Maximo
    Pino, Rosario
    Roblero, Juan P.
    Urzua, Alvaro
    Rojas, Katherine
    Poniachik, Jaime
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [8] Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
    Giovanni Alejandro Salgado Alvarez
    Samanta Mayanin Pinto Galvez
    Uriel Garcia Mora
    Ana Delfina Cano Contreras
    Cristina Durán Rosas
    Bryan Adrián Priego-Parra
    Arturo Triana Romero
    Mercedes Amieva Balmori
    Federico Roesch Dietlen
    Sophia Eugenia Martinez Vazquez
    Ines Osvely Mendez Guerrero
    Luis Alberto Chi-Cervera
    Raúl Bernal Reyes
    Leonardo Alberto Martinez Roriguez
    Maria Eugenia Icaza Chavez
    Jose Maria Remes Troche
    World Journal of Hepatology, 2022, (08) : 1633 - 1642
  • [9] Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments
    Yanai, Hidekatsu
    Adachi, Hiroki
    Hakoshima, Mariko
    Iida, Sakura
    Katsuyama, Hisayuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [10] Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue
    Savino, Alberto
    Loglio, Alessandro
    Neri, Flavia
    Camagni, Stefania
    Pasulo, Luisa
    Luca, Maria Grazia
    Trevisan, Roberto
    Fagiuoli, Stefano
    Vigano, Mauro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)